245 related articles for article (PubMed ID: 9142133)
1. Corticotropin-releasing factor (CRF) and endocrine responses to stress: CRF receptors, binding protein, and related peptides.
Turnbull AV; Rivier C
Proc Soc Exp Biol Med; 1997 May; 215(1):1-10. PubMed ID: 9142133
[TBL] [Abstract][Full Text] [Related]
2. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor.
Vaughan J; Donaldson C; Bittencourt J; Perrin MH; Lewis K; Sutton S; Chan R; Turnbull AV; Lovejoy D; Rivier C
Nature; 1995 Nov; 378(6554):287-92. PubMed ID: 7477349
[TBL] [Abstract][Full Text] [Related]
3. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor.
Lewis K; Li C; Perrin MH; Blount A; Kunitake K; Donaldson C; Vaughan J; Reyes TM; Gulyas J; Fischer W; Bilezikjian L; Rivier J; Sawchenko PE; Vale WW
Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7570-5. PubMed ID: 11416224
[TBL] [Abstract][Full Text] [Related]
4. Urocortin is the principal ligand for the corticotrophin-releasing factor binding protein in the ovine brain with no evidence for a sauvagine-like peptide.
Baigent SM; Lowry PJ
J Mol Endocrinol; 2000 Feb; 24(1):53-63. PubMed ID: 10656997
[TBL] [Abstract][Full Text] [Related]
5. Evolution and physiology of the corticotropin-releasing factor (CRF) family of neuropeptides in vertebrates.
Lovejoy DA; Balment RJ
Gen Comp Endocrinol; 1999 Jul; 115(1):1-22. PubMed ID: 10375459
[TBL] [Abstract][Full Text] [Related]
6. Urocortin interaction with corticotropin-releasing factor (CRF) binding protein (CRF-BP): a novel mechanism for elevating "free' CRF levels in human brain.
Behan DP; Khongsaly O; Ling N; De Souza EB
Brain Res; 1996 Jul; 725(2):263-7. PubMed ID: 8836534
[TBL] [Abstract][Full Text] [Related]
7. Ligand requirements of the human corticotropin-releasing factor-binding protein.
Sutton SW; Behan DP; Lahrichi SL; Kaiser R; Corrigan A; Lowry P; Potter E; Perrin MH; Rivier J; Vale WW
Endocrinology; 1995 Mar; 136(3):1097-102. PubMed ID: 7867564
[TBL] [Abstract][Full Text] [Related]
8. Corticotropin-releasing factor-binding protein (CRF-BP) inhibits CRF- and urotensin-I-mediated activation of CRF receptor-1 and -2 in common carp.
Manuel R; Metz JR; Flik G; Vale WW; Huising MO
Gen Comp Endocrinol; 2014 Jun; 202():69-75. PubMed ID: 24769042
[TBL] [Abstract][Full Text] [Related]
9. 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.
Grigoriadis DE; Liu XJ; Vaughn J; Palmer SF; True CD; Vale WW; Ling N; De Souza EB
Mol Pharmacol; 1996 Sep; 50(3):679-86. PubMed ID: 8794910
[TBL] [Abstract][Full Text] [Related]
10. Cloning and functional pharmacology of two corticotropin-releasing factor receptors from a teleost fish.
Pohl S; Darlison MG; Clarke WC; Lederis K; Richter D
Eur J Pharmacol; 2001 Nov; 430(2-3):193-202. PubMed ID: 11711031
[TBL] [Abstract][Full Text] [Related]
11. Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors.
Reyes TM; Lewis K; Perrin MH; Kunitake KS; Vaughan J; Arias CA; Hogenesch JB; Gulyas J; Rivier J; Vale WW; Sawchenko PE
Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2843-8. PubMed ID: 11226328
[TBL] [Abstract][Full Text] [Related]
12. Widespread tissue distribution and diverse functions of corticotropin-releasing factor and related peptides.
Boorse GC; Denver RJ
Gen Comp Endocrinol; 2006 Mar; 146(1):9-18. PubMed ID: 16413023
[TBL] [Abstract][Full Text] [Related]
13. Actions of CRF and its analogs.
Eckart K; Radulovic J; Radulovic M; Jahn O; Blank T; Stiedl O; Spiess J
Curr Med Chem; 1999 Nov; 6(11):1035-53. PubMed ID: 10519912
[TBL] [Abstract][Full Text] [Related]
14. Physiological roles of urocortins, human homologues of fish urotensin I, and their receptors.
Suda T; Kageyama K; Sakihara S; Nigawara T
Peptides; 2004 Oct; 25(10):1689-701. PubMed ID: 15476936
[TBL] [Abstract][Full Text] [Related]
15. A single amino acid serves as an affinity switch between the receptor and the binding protein of corticotropin-releasing factor: implications for the design of agonists and antagonists.
Eckart K; Jahn O; Radulovic J; Tezval H; van Werven L; Spiess J
Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11142-7. PubMed ID: 11572971
[TBL] [Abstract][Full Text] [Related]
16. An artificial peptide with corticotropin-releasing factor receptor-2 (CRF-R2) selective properties: the role of primary structure in the induction of signal transduction pathways.
Tellam DJ; Smart D; Qian X; Lovejoy DA
J Pept Res; 2002 Oct; 60(4):215-22. PubMed ID: 12366528
[TBL] [Abstract][Full Text] [Related]
17. Corticotropin releasing factor (CRF) binding protein: a novel regulator of CRF and related peptides.
Behan DP; De Souza EB; Lowry PJ; Potter E; Sawchenko P; Vale WW
Front Neuroendocrinol; 1995 Oct; 16(4):362-82. PubMed ID: 8557170
[TBL] [Abstract][Full Text] [Related]
18. Corticotropin-releasing factor antagonists, binding-protein and receptors: implications for central nervous system disorders.
Heinrichs SC; De Souza EB
Baillieres Best Pract Res Clin Endocrinol Metab; 1999 Dec; 13(4):541-54. PubMed ID: 10903813
[TBL] [Abstract][Full Text] [Related]
19. Corticotropin-releasing factor (CRF), but not corticosterone, increases basolateral amygdala CRF-binding protein.
Herringa RJ; Mackenrodt DB; Barlow JD; Roseboom PH; Nanda SA; Kalin NH
Brain Res; 2006 Apr; 1083(1):21-8. PubMed ID: 16545343
[TBL] [Abstract][Full Text] [Related]
20. Urocortin expression in rat brain: evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors.
Bittencourt JC; Vaughan J; Arias C; Rissman RA; Vale WW; Sawchenko PE
J Comp Neurol; 1999 Dec; 415(3):285-312. PubMed ID: 10553117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
